Overview

PK Study of ACHN-490 Injection in Renally Impaired Subjects

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purposes of this study is to assess the relationship between renal function and pharmacokinetics of ACHN-490 Injection.
Phase:
Phase 1
Details
Lead Sponsor:
Achaogen, Inc.
Collaborator:
Department of Health and Human Services